Takahiko Baba

Different Contribution of CYP2C19 in the in Vitro Metabolism of Three Proton Pump Inhibitors.

Tomoko Kita, Toshiyuki Sakaeda, Takahiko Baba et al. · Biological and Pharmaceutical Bulletin · 2003 · 43 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +16

Assessment of the hepatic and intestinal first-pass metabolism of midazolam in a CYP3A drug–drug interaction model rats

Takushi Kanazu, Noboru Okamura, Yoshitaka Yamaguchi et al. · Xenobiotica · 2005 · 42 citations

Pharmacy, Pharmacokinetics, Pharmacology +17

2-Arylimino-5,6-dihydro-4H-1,3-thiazines as a new class of cannabinoid receptor agonists. Part 2: Orally bioavailable compounds

Hiroyuki Kai, Yasuhide Morioka, Minoru Tomida et al. · Bioorganic & Medicinal Chemistry Letters · 2007 · 36 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +9

Adjuvant effect of zinc oxide on Th2 but not Th1 immune responses in mice

Misa Matsumura, Masafumi Nagata, Kazuichi Nakamura et al. · Immunopharmacology and Immunotoxicology · 2009 · 32 citations

Life Sciences, Immunology, Adaptive Immunity +12

2-Arylimino-5,6-dihydro-4H-1,3-thiazines as a new class of cannabinoid receptor agonists. Part 1: Discovery of CB2 receptor selective compounds

Hiroyuki Kai, Yasuhide Morioka, Takami Murashi et al. · Bioorganic & Medicinal Chemistry Letters · 2007 · 31 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +10